首頁 > 市場調查報告書 > 製藥

蝨子治療藥物市場規模、佔有率和成長分析（按產品類型、給藥途徑、症狀、劑型、分銷管道和地區）-產業預測（2025-2032）

市場調查報告書

商品編碼

1758578

蝨子治療藥物市場規模、佔有率和成長分析（按產品類型、給藥途徑、症狀、劑型、分銷管道和地區）-產業預測（2025-2032）

Lice Treatment Market Size, Share, and Growth Analysis, By Product Type, By Type, By Route of Administration, By Condition, By Dosage Form, By Distribution Channel, By Region - Industry Forecast 2025-2032

出版日期: 2025年06月19日 | 出版商:

SkyQuest | 英文 193 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球蝨子治療藥物市場規模為 22 億美元，預計將從 2024 年的 23.5 億美元成長到 2032 年的 40.1 億美元，預測期內（2025-2032 年）的複合年成長率為 6.9%。

蝨子治療藥物市場預計將蓬勃發展，這得益於多個關鍵因素，例如蝨子患病率的上升、非處方藥的便捷獲取以及治療配方的創新進步。政府的健康計劃以及人們對天然無毒產品的日益偏好，進一步推動了全球市場的需求。在學校等擁擠的環境中，蝨子發病率不斷上升，加之線上零售平台的便利性提升，產品供應也隨之增加，這為企業拓展市場提供了機會。然而，到2032年，諸如化學療法抗藥性日益增強、潛在的副作用、低收入地區獲取藥物的管道有限以及社會歧視等挑戰可能會阻礙市場滲透。綜上所述，這些見解凸顯了蝨子治療藥物領域的成長潛力和限制。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業市場定位（2024年）
主要企業採取的策略
近期市場趨勢
主要企業市場佔有率（2024年）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分析市場佔有率
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Johnson & Johnson Services, Inc.（USA）
Reckitt Benckiser Group plc（UK）
Perrigo Company plc（Ireland）
Prestige Consumer Healthcare Inc.（USA）
Sanofi SA（France）
GlaxoSmithKline（GSK）plc（UK）
Teva Pharmaceutical Industries Ltd.（Israel）
Pfizer Inc.（USA）
F. Hoffmann-La Roche Ltd.（Switzerland）
Sun Pharmaceutical Industries Ltd.（India）
ParaPRO LLC.（USA）
Alliance Pharma PLC（UK）
Arbor Pharmaceuticals, LLC.（USA）
Oystershell Consumer Health（Belgium）
Taro Pharmaceuticals（Canada）
ICB PHARMA（Poland）
Lice Clinics of America（USA）

結論和建議

簡介目錄

Product Code: SQMIG35D2312

Global Lice Treatment Market size was valued at USD 2.2 billion in 2023 and is poised to grow from USD 2.35 billion in 2024 to USD 4.01 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The lice treatment market is expected to flourish due to several key factors, including the rising prevalence of lice infestations, easy access to over-the-counter treatments, and innovative advancements in treatment formulations. Government health initiatives and a growing preference for natural, non-toxic products further bolster global market demand. Increased occurrences of lice in overcrowded environments, like schools, alongside the convenience of online retail platforms, enhance product accessibility and market expansion opportunities for companies. However, challenges such as rising resistance to chemical treatments, potential side effects, limited access in low-income areas, and social stigma may hinder market penetration through 2032. Collectively, these insights highlight both the growth potential and limitations within the lice treatment sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lice Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lice Treatment Market Segments Analysis

Global Lice Treatment Market is segmented by Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel and region. Based on Product Type, the market is segmented into OTC products and Prescription medications. Based on Type, the market is segmented into Branded and Generic. Based on Route of Administration, the market is segmented into Oral and Topical. Based on Condition, the market is segmented into Pediculosis capitis, Pediculosis corporis and Pediculosis pubis. Based on Dosage Form, the market is segmented into Tablets, Shampoos, Lotions, Cream and Other dosage forms. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail pharmacies and Other distribution channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lice Treatment Market

The Global Lice Treatment market is being propelled by innovations in treatment formulations that significantly enhance both effectiveness and user safety. Modern products, particularly those that are non-pesticide and silicone-based, effectively immobilize lice without relying on neurotoxins, thereby minimizing the risk of resistance. These advanced treatments are often odorless, cause less irritation, and require shorter application times, which ultimately improves the user experience. As a result, consumers are more likely to trust and feel satisfied with these options, leading to increased repeat purchases and positively impacting the market's growth trajectory in the coming years.

Restraints in the Global Lice Treatment Market

The global lice treatment market faces significant restraints due to the increasing resistance of lice to commonly used treatments. Chemical agents like permethrin and pyrethrin, which were once effective, have lost their potency due to overuse, resulting in treatment failures that frustrate consumers and lead to a decline in brand trust and repeat purchases. The emergence of "super lice," which are resistant to multiple chemical formulations, further complicates treatment options and underscores the need for alternative solutions. As a result, the growing demand for non-chemical treatments has contributed to a slowdown in the overall growth of the lice treatment industry.

Market Trends of the Global Lice Treatment Market

The Global Lice Treatment market is witnessing a significant trend towards preventive care, shifting from traditional reactive treatments to proactive measures. Parents and educational institutions are increasingly prioritizing strategies aimed at preventing lice infestations, resulting in heightened demand for products such as lice-repelling shampoos, sprays, and combs, especially those enriched with essential oils like rosemary and eucalyptus. This focus on prevention is not only broadening the product offering but also encouraging consumers to adopt consistent, long-term usage patterns. As awareness around lice prevention grows, the global market is expected to expand, catering to a more health-conscious demographic seeking effective solutions to combat lice infestations.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Lice Treatment Market Size by Product Type & CAGR (2025-2032)

Market Overview
OTC products
- Permethrin
- Pyrethrin
- Other OTC products
Prescription medications
- Ivermectin
- Spinosad
- Malathion
- Other prescription medications

Global Lice Treatment Market Size by Type & CAGR (2025-2032)

Market Overview
Branded
Generic

Global Lice Treatment Market Size by Route of Administration & CAGR (2025-2032)

Market Overview
Oral
Topical

Global Lice Treatment Market Size by Condition & CAGR (2025-2032)

Market Overview
Pediculosis capitis
Pediculosis corporis
Pediculosis pubis

Global Lice Treatment Market Size by Dosage Form & CAGR (2025-2032)

Market Overview
Tablets
Shampoos
Lotions
Cream
Other dosage forms

Global Lice Treatment Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Hospital pharmacies
Retail pharmacies
Other distribution channels

Global Lice Treatment Market Size & CAGR (2025-2032)

North America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- US
- Canada
Europe (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Johnson & Johnson Services, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reckitt Benckiser Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prestige Consumer Healthcare Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline (GSK) plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ParaPRO LLC. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alliance Pharma PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arbor Pharmaceuticals, LLC. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oystershell Consumer Health (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taro Pharmaceuticals (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICB PHARMA (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lice Clinics of America (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments